Robert Califf Nominated To Retake FDA Commissioner Role
Clinical Trial Reform, Staff 'Brain Drain' Among Familiar Challenges Awaiting Cardiologist
President Biden’s pick for FDA commissioner should remember many of the hot-button issues that he would face if confirmed to a second stint as the nation's top medtech regulator.
You may also be interested in...
While former FDA commissioner Califf was likely picked to head the agency again because he’s already been vetted, some Republicans may use his nomination as a political opportunity to deny Biden a win.
Acting FDA commissioner Janet Woodcock’s latest appearance before Senate Health Committee shows once again she could easily win enough votes for Senate confirmation in the job – and why she most likely won’t get the chance.
The once and likely future FDA commissioner emphasized the value of randomized controlled trials, the fact that not all trials are good for people, and how decentralization and digitization are leaving people behind during a panel discussion.